Related Experiment Video
Updated: May 18, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America
Claudia P Oliveira1, Mario Guimarães Pessoa1, Luis Antonio Diaz2
1Departamento de Gastroenterologia, Hospital das Clínicas (LIM 07) da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major public health concern in Latin America, where prevalence exceeds 40%. A high frequency of genetic risk variants, particularly the PNPLA3 risk allele, contributes to greater disease prevalence and severity across the region. Fragmented health systems, shortages of trained personnel, and limited access to advanced noninvasive diagnostic tools and emerging pharmacotherapies constrain MASLD effective care in the region. These structural barriers highlight the need for coordinated public health strategies to expand screening, strengthen diagnostic capacity, and improve equitable access to treatment. This review summarizes regional epidemiology, diagnostic gaps, and health system priorities for addressing MASLD in Latin America.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cirrhosis II: Pathophysiology
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Inborn Errors of Metabolism
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...

